These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37028836)

  • 1. Gastrointestinal Tract Considerations Part I: How Should a Rheumatologist Best Manage Common Upper Gastrointestinal Tract Complaints in Systemic Sclerosis?
    Quinlivan A; McMahan ZH; Lee EB; Nikpour M
    Rheum Dis Clin North Am; 2023 May; 49(2):295-318. PubMed ID: 37028836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Tract Considerations: Part II: How Should a Rheumatologist Best Manage Common Lower Gastrointestinal Tract Complaints in Systemic Sclerosis?
    Quinlivan A; McMahan ZH; Lee EB; Nikpour M
    Rheum Dis Clin North Am; 2023 May; 49(2):319-336. PubMed ID: 37028837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and the gut.
    Butt S; Emmanuel A
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring response in the gastrointestinal tract in systemic sclerosis.
    Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
    Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.
    Gyger G; Baron M
    Curr Rheumatol Rep; 2012 Feb; 14(1):22-9. PubMed ID: 22105546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
    Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
    Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign.
    Zuber-Jerger I; Müller A; Kullmann F; Gelbmann CM; Endlicher E; Müller-Ladner U; Fleck M
    Rheumatology (Oxford); 2010 Feb; 49(2):368-72. PubMed ID: 20008473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.
    Kaniecki T; Abdi T; McMahan ZH
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101666. PubMed ID: 33676855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of gastrointestinal manifestations in scleroderma.
    Kirby DF; Chatterjee S
    Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal manifestations in Hungarian scleroderma patients.
    Szamosi S; Szekanecz Z; Szucs G
    Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal symptoms in scleroderma patients and its influence in body mass index and quality of life.
    Skare T; Culpi M; Yokoo P; Dias M
    Acta Reumatol Port; 2014; 39(3):242-7. PubMed ID: 25326404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
    Volkmann ER; McMahan Z
    Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis.
    Bae S; Allanore Y; Furst DE; Bodukam V; Coustet B; Morgaceva O; Maranian P; Khanna D
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):57-63. PubMed ID: 23910611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
    Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
    J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal involvement in systemic sclerosis: An updated review.
    Nassar M; Ghernautan V; Nso N; Nyabera A; Castillo FC; Tu W; Medina L; Ciobanu C; Alfishawy M; Rizzo V; Eskaros S; Mahdi M; Khalifa M; El-Kassas M
    Medicine (Baltimore); 2022 Nov; 101(45):e31780. PubMed ID: 36397401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal complications of systemic sclerosis.
    Tian XP; Zhang X
    World J Gastroenterol; 2013 Nov; 19(41):7062-8. PubMed ID: 24222949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis.
    Nagaraja V; Hays RD; Khanna PP; Spiegel BM; Chang L; Melmed GY; Bolus R; Khanna D
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1725-30. PubMed ID: 24692332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early endoscopy in systemic sclerosis without gastrointestinal symptoms.
    Thonhofer R; Siegel C; Trummer M; Graninger W
    Rheumatol Int; 2012 Jan; 32(1):165-8. PubMed ID: 20711592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal manifestations of systemic sclerosis.
    Abu-Shakra M; Guillemin F; Lee P
    Semin Arthritis Rheum; 1994 Aug; 24(1):29-39. PubMed ID: 7985035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.
    McMahan ZH; Kulkarni S; Chen J; Chen JZ; Xavier RJ; Pasricha PJ; Khanna D
    Nat Rev Rheumatol; 2023 Mar; 19(3):166-181. PubMed ID: 36747090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.